FDA Approved: CEFUROXIME — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Cefuroxime, adding an additional approved use/formulation under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Otitis Media
• Pyelonephritis
• Skin and Soft Tissue Infections
• Urinary Tract Infection

Drugs mentioned

• cefuroxime (cefuroxime)

Snippet

SUPPL AP for CEFUROXIME (CEFUROXIME)